Zealand Pharma A/s Stock
€56.78
Your prediction
Zealand Pharma A/s Stock
Pros and Cons of Zealand Pharma A/s in the next few years
Pros
Cons
Performance of Zealand Pharma A/s vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Zealand Pharma A/s | -2.420% | -11.254% | -16.745% | -40.420% | -11.254% | 108.597% | - |
| Saniona AB | -0.420% | -0.209% | 8.381% | 212.235% | -0.209% | 604.972% | -9.289% |
| Actinium Pharmaceuticals Inc. | 1.630% | 2.817% | 1.389% | -8.278% | 2.817% | -86.895% | -82.271% |
| NanoViricides Inc. | -1.830% | 15.054% | 2.885% | -31.410% | 15.054% | -14.843% | -57.874% |
News
Why 2026 Could Be Another Breakout Year for Rocket Lab
The momentum has shown little sign of slowing for Rocket Lab (NASDAQ: RKLB). Shares of the aerospace and defense company have gone from strength to strength, rising roughly 1,775% over the past
New APAC Partnership with Matter Brings Market Logic Software's Always-On Insights Solutions to Local Brand and Experience Leaders
BERLIN, DE / ACCESS Newswire / December 16, 2025 / Market Logic Software, the market-leading SaaS provider of insight management solutions, has announced a partnership with Matter, a New
Why Rocket Lab Stock Keeps Going Up
Rocket Lab (NASDAQ: RKLB) stock rocketed to a 10th straight day of gains Friday, surging 5.7% through 11:15 a.m. ET after announcing the New Zealand-based space company announced yet another big


